PhoenixBio Co., Ltd. (6190.T)
JPY 335.0
(-1.76%)
JPY 335.0
(-1.76%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 450.58 Million JPY | 23.37% |
| 2022 | 365.23 Million JPY | 41.46% |
| 2021 | 258.19 Million JPY | -7.48% |
| 2020 | 279.06 Million JPY | 25.1% |
| 2019 | 223.07 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 450 Million JPY | -0.13% |
| 2023 Q4 | 450.58 Million JPY | 3.92% |
| 2023 Q3 | 433.57 Million JPY | 1.72% |
| 2023 Q1 | 439.24 Million JPY | 20.26% |
| 2023 Q2 | 426.25 Million JPY | -2.96% |
| 2023 FY | 450.58 Million JPY | 23.37% |
| 2022 Q3 | 334 Million JPY | 10.39% |
| 2022 Q2 | 302.55 Million JPY | 0.0% |
| 2022 Q4 | 365.23 Million JPY | 9.35% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 34.029% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -2413.174% |
| GNI Group Ltd. | 2.33 Billion JPY | 80.667% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 79.773% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -567.724% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 59.8% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | -335.207% |
| AnGes, Inc. | 1.61 Billion JPY | 72.114% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -508.91% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 84.479% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | -39.972% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -244784.239% |
| Carna Biosciences, Inc. | 140.14 Million JPY | -221.526% |
| CanBas Co., Ltd. | 728 Thousand JPY | -61793.819% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -412.829% |
| RaQualia Pharma Inc. | 147.93 Million JPY | -204.576% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -602.867% |
| Kidswell Bio Corporation | 875.65 Million JPY | 48.543% |
| PeptiDream Inc. | 2.4 Billion JPY | 81.258% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -8334.8% |
| Ribomic Inc. | 2.27 Million JPY | -19714.732% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -45058699900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -1151.631% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -1453.748% |
| CellSource Co., Ltd. | 305.92 Million JPY | -47.287% |
| FunPep Company Limited | 25.54 Million JPY | -1664.171% |
| Kringle Pharma, Inc. | 364.05 Million JPY | -23.769% |
| Stella Pharma Corporation | 1.11 Billion JPY | 59.634% |
| TMS Co., Ltd. | 50.02 Million JPY | -800.724% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -2055.816% |
| Cuorips Inc. | 1.04 Million JPY | -43101.055% |
| K Pharma,Inc. | 10.79 Million JPY | -4074.421% |
| Takara Bio Inc. | 11.85 Billion JPY | 96.198% |
| ReproCELL Incorporated | 248.14 Million JPY | -81.586% |
| StemCell Institute Inc. | 42.26 Million JPY | -966.175% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | -97.137% |
| CellSeed Inc. | 46.19 Million JPY | -875.487% |